FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/12/2026
Back to search
Official data from USPTO
IASO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
08/12/2026
Trademark type
Combined
Nice classes
5
Filing date
11/01/2024
Registration date
05/12/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/12/2026
Last transaction
08/12/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
CN
Examiner
RATCLIFFE, ROBERT L
Law office
L90
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
This trademark consists of the stylized lettering "IASO" surrounded by a running reindeer with a flame on its head.
Holders and representatives
Holders
Nanjing IASO Biotechnology Co., Ltd.
Representatives
Yue Robert Xu Apex Attorneys at Law, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicines for the treatment of cardiovascular and cerebrovascular diseases; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations for use in chemotherapy; tumor suppressing agents; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; biological preparations for the treatment of tumor; biological preparations for medical purposesfor the treatment of tumorendocrinemetaboliccentral nervous system disordersautoimmune disorders and blood disorders; pharmaceutical products for the treatment of viral and infectious diseasesfor the treatment of cancer; biochemical preparations for medical purposesfor the treatment of tumorendocrinemetaboliccentral nervous system disordersautoimmune disorders and blood disorders; reagents for use in medical genetic testing; pharmaceutical products for the prevention and treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical products for the treatment of cancer; medical diagnostic reagents; anti-cancer preparations; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; cytostatics for medical purposes; cells for medical use; antivirals; pharmaceutical preparations for the treatment of immune system related diseases and disorders; yeast extracts for medicalveterinary or pharmaceutical purposes
Publications
History of USPTO decisions and trademark events.
25 publications found
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/04/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/18/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/18/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/12/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
05/12/2026
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
04/16/2026
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
10/16/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/07/2025
PUBO
PUBLISHED FOR OPPOSITION
10/07/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/01/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/05/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/16/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/16/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/16/2025
RFNT
REFUSAL PROCESSED BY IB
07/05/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/17/2025
RFRR
REFUSAL PROCESSED BY MPU
06/17/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/16/2025
CNRT
NON-FINAL ACTION WRITTEN
04/15/2025
DOCK
ASSIGNED TO EXAMINER
03/27/2025
MAFR
APPLICATION FILING RECEIPT MAILED
01/03/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/03/2025
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
12/31/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/19/2024
Continuous trademark protection
Get notified about every new filing that threatens IASO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.